Short-course combination treatment for experimental chronic Chagas disease

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects millions of people in the Americas and across the world leading to considerable morbidity and mortality. Current treatment options, benznidazole (BNZ) and nifurtimox, offer limited efficacy and often lead to adverse side eff...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Sci Transl Med
Κύριοι συγγραφείς: González, Silvia, Wall, Richard J., Thomas, John, Braillard, Stephanie, Brunori, Gino, Díaz, Isabel Camino, Cantizani, Juan, Carvalho, Sandra, Castañeda Casado, Pablo, Chatelain, Eric, Cotillo, Ignacio, Fiandor, Jose M., Francisco, Amanda Fortes, Grimsditch, David, Keenan, Martine, Kelly, John M., Kessler, Albane, Luise, Chiara, Lyon, Jon J., MacLean, Lorna, Marco, Maria, Martin, J. Julio, Martinez, Maria S., Paterson, Christy, Read, Kevin D., Santos-Villarejo, Angel, Zuccotto, Fabio, Wyllie, Susan, Miles, Tim J., De Rycker, Manu
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2023
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7615676/
https://ncbi.nlm.nih.gov/pubmed/38091410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.adg8105
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια